Saturday, December 10, 2022 2:47:18 PM
Don’t know whether the Biden admin is aware yet, however they have a great opportunity to get behind, and of course take some credit for, the potentially broad breakthrough platform of Dcvax and combo treatments across solid tumor cancers -
Can you say Moonshot? I knew you could!
Biden especially has the closest of ties to GBM, which DCVax L immediately is a victory (both personally for Biden I would think, and politically.)
And also imminently the amazingly great promise that DCVax-PD1 is indicating, and which could be in practice very quickly especially with admin support.
Then at the same time the moonshot umbrella can facilitate multiple parallel studies and trials across the most needed cancers or as many as could be pursued.
This could transform, at least for immunotherapy and DCVax in particular, a more serial attack on cancer into a geometrically expanding attack!!!
Maybe too much caffeine today?
Can you say Moonshot? I knew you could!
Biden especially has the closest of ties to GBM, which DCVax L immediately is a victory (both personally for Biden I would think, and politically.)
And also imminently the amazingly great promise that DCVax-PD1 is indicating, and which could be in practice very quickly especially with admin support.
Then at the same time the moonshot umbrella can facilitate multiple parallel studies and trials across the most needed cancers or as many as could be pursued.
This could transform, at least for immunotherapy and DCVax in particular, a more serial attack on cancer into a geometrically expanding attack!!!
Maybe too much caffeine today?
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
